SecSonar.com

Personalis, Inc. (PSNL)

Personalis, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Personalis, Inc. (PSNL) is a Medical - Diagnostics & Research company based in US with a market capitalization of $1B. Free cash flow was negative at -$79.5M. This page tracks PSNL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 228 employees · IPO Jun 20, 2019

Valuation

Valuation & price

$6.36 · as of May 17, 2026 · -53.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.89

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$13.62$9.02$4.41Jul 25Dec 25Jul 26Jul 7, 25$6.68Jul 9, 25$7.16Jul 11, 25$6.37Jul 15, 25$6.31Jul 17, 25$6.48Jul 21, 25$6.20Jul 23, 25$6.76Jul 25, 25$6.49Jul 29, 25$5.58Jul 31, 25$5.48Aug 4, 25$5.57Aug 6, 25$4.41Aug 11, 25$4.50Aug 13, 25$4.83Aug 15, 25$4.60Aug 19, 25$4.53Aug 21, 25$4.66Aug 25, 25$4.70Aug 27, 25$4.78Aug 29, 25$4.89Sep 3, 25$4.85Sep 5, 25$5.24Sep 9, 25$5.39Sep 11, 25$6.10Sep 16, 25$5.87Sep 18, 25$5.82Sep 22, 25$6.16Sep 24, 25$6.06Sep 26, 25$6.04Sep 30, 25$6.52Oct 2, 25$6.77Oct 6, 25$7.20Oct 8, 25$8.68Oct 10, 25$8.12Oct 14, 25$8.22Oct 16, 25$10.28Oct 21, 25$9.57Oct 23, 25$9.45Oct 27, 25$9.68Oct 29, 25$9.55Oct 31, 25$9.64Nov 4, 25$8.73Nov 6, 25$7.19Nov 10, 25$8.63Nov 12, 25$8.01Nov 14, 25$7.51Nov 18, 25$7.62Nov 20, 25$8.28Nov 25, 25$11.21Nov 28, 25$10.73Dec 2, 25$10.10Dec 4, 25$10.48Dec 8, 25$9.82Dec 10, 25$9.27Dec 12, 25$8.77Dec 16, 25$7.98Dec 18, 25$7.93Dec 22, 25$8.72Dec 24, 25$8.41Dec 29, 25$7.93Jan 2, 26$7.85Jan 6, 26$9.15Jan 8, 26$8.38Jan 12, 26$8.57Jan 14, 26$9.30Jan 16, 26$9.89Jan 21, 26$9.65Jan 23, 26$10.17Jan 27, 26$10.32Jan 29, 26$9.97Feb 2, 26$9.35Feb 4, 26$8.31Feb 9, 26$7.83Feb 11, 26$8.90Feb 13, 26$8.21Feb 18, 26$9.00Feb 20, 26$8.28Feb 24, 26$8.29Feb 26, 26$9.03Mar 2, 26$9.06Mar 4, 26$8.93Mar 6, 26$7.84Mar 10, 26$8.31Mar 12, 26$6.59Mar 17, 26$7.12Mar 19, 26$7.19Mar 23, 26$7.61Mar 25, 26$7.70Mar 27, 26$6.34Mar 31, 26$6.37Apr 2, 26$6.58Apr 7, 26$6.17Apr 9, 26$6.09Apr 13, 26$6.31Apr 15, 26$6.63Apr 17, 26$6.73Apr 22, 26$6.31Apr 24, 26$6.10Apr 28, 26$5.50Apr 30, 26$5.52May 4, 26$5.90May 6, 26$6.07May 8, 26$5.98May 12, 26$6.04May 14, 26$6.71May 18, 26$6.72May 20, 26$7.95May 22, 26$8.47May 28, 26$10.98Jun 1, 26$11.26Jun 3, 26$10.78Jun 5, 26$10.75Jun 9, 26$9.75Jun 11, 26$9.42Jun 15, 26$9.79Jun 17, 26$9.75Jun 22, 26$10.17Jun 24, 26$11.36Jun 26, 26$13.02Jul 2, 26$13.62
$4.4152-week range$13.79
Loading valuation history…

Fundamentals

Key fundamentals

$1B

Market cap

—

Revenue growth (YoY)

31.7%

Gross margin

-$79.5M

Free cash flow (USD)

-$208.1M

Net debt

Net cash position

50.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$9.4MFY 2018$37.8MFY 2019$65.2MFY 2020$78.6MFY 2021$85.5MFY 2022$65.0MFY 2023$73.5MFY 2024$84.6MFY 2025$0.00
$9.4M$0

Free cash flow by year

2017 → 2025

FY 2017$-4.9MFY 2018$-2.3MFY 2019$-26.5MFY 2020$-45.9MFY 2021$-81.9MFY 2022$-120.1MFY 2023$-67.2MFY 2024$-46.8MFY 2025$-79.5M
-$4.9M-$79.5M

Gross margin by year

2021 → 2024

FY 202137.0%FY 202220.5%FY 202324.8%FY 202431.7%
37.0%31.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

6

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $70K · 10b5-1 PlanTachibana Aaron · CFO AND COO · $69.7KJun 29, 2026Filing
  • Insider sellInsider Sell $1.3M · 10b5-1 PlanHall Christopher M · Director, Chief Executive Officer · $1.3MJun 26, 2026Filing
  • Insider sellInsider Sell $675K · 10b5-1 PlanTachibana Aaron · CFO AND COO · $675.5KJun 26, 2026Filing
  • Insider sellInsider Sell $480K · 10b5-1 PlanTachibana Aaron · CFO AND COO · $480.4KJun 5, 2026Filing
  • Insider sellInsider Sell $449K · 10b5-1 PlanTachibana Aaron · CFO AND COO · $449.3KMay 29, 2026Filing
  • Insider sellInsider Sell $1.1M · 10b5-1 PlanHall Christopher M · Director, Chief Executive Officer · $1.1MMay 29, 2026Filing
  • 8-K eventMedicare Coverage ExpansionMay 20, 2026Filing
  • 8-K eventMedicare Coverage ExpansionMay 13, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing

Questions

Frequently asked questions

What is Personalis, Inc.'s market cap?

Personalis, Inc. (PSNL) has a market capitalization of $1B.

What is PSNL's P/E ratio?

A meaningful P/E ratio is not available for PSNL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PSNL's price-to-book (P/B) ratio?

PSNL trades at 3.89 times book value per share.

Are insiders buying PSNL stock?

SEC Form 4 filings show no open-market insider buys at Personalis, Inc. in the last 90 days (6 sells).

Same arena

Related companies in Medical - Diagnostics & Research

CDNA

CareDx, Inc

$1.2B

CSTL

Castle Biosciences, Inc.

$640.9M

FLGT

Fulgent Genetics, Inc.

$528.9M

MYGN

Myriad Genetics, Inc.

$378.3M

PRE

Prenetics Global Limited

$360.1M

NEO

NeoGenomics, Inc.

$276.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.